VM
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Microcavity-assisted cloning (MAC) of hard-to-clone HepG2 cell lines : cloning made easy | BMC biotechnology |  | 2024 | 17 | 31 | ||
| 17q Gain in Neuroblastoma : A Review of Clinical and Biological Implications | Cancers | | 2024 | 17 | 86 | ||
| Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11 | Frontiers in oncology | | 2024 | 11 | 71 | ||
| GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation | Journal of cancer research and clinical oncology | | 2022 | 388 | 188 | ||
| The Catalytic Activity of GSTM1 In vitro is Independent of MAPK8 | Drug metabolism letters | | 2021 | 102 | 79 | ||
| A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma | Journal of experimental & clinical cancer research | | 2021 | 247 | 241 | ||
| The analysis of GSTA1 promoter genetic and functional diversity of human populations | Scientific reports | | 2021 | 279 | 263 | ||
| 4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation | Pharmacogenomics | | 2019 | 312 | 537 | ||
| The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review | International Journal of Molecular Sciences | | 2019 | 333 | 292 | ||
| PRIMA-1MET-induced neuroblastoma cell death is modulated by p53 and mycn through glutathione level | Journal of Experimental & Clinical Cancer Research | | 2019 | 317 | 422 | ||
| 4th ESPT summer school: precision medicine and personalised health | Pharmacogenomics | | 2019 | 272 | 128 | ||
| 11q deletion in neuroblastoma: a review of biological and clinical implications | Molecular Cancer | | 2017 | 490 | 348 | ||
| Creation of the Swiss group of Pharmacogenomics and personalised Therapy (SPT) | Drug Metabolism and Personalized Therapy |  | 2017 | 533 | 1 | ||
| GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study | Oncotarget | | 2017 | 556 | 270 | ||
| The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation | Frontiers in Pharmacology | | 2017 | 619 | 264 | ||
| 8th Santorini Conference: Systems medicine and personalized health and therapy, Santorini, Greece, 3-5 October 2016 | Drug Metabolism and Personalized Therapy | | 2017 | 575 | 3 | ||
| Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use | International Journal of Molecular Sciences | | 2016 | 583 | 485 | ||
| Creation of the Swiss group of pharmacogenomics and personalized therapy (SPT) | Paediatrica | | 2016 | 380 | 105 |
